Study to Assess the Effect on Recovery of GI Motility and Safety and to Determine the Optimal Dose of LD02GIFRO

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

LG Life Sciences

ClinicalTrials.gov Identifier:

NCT01624571

First received: June 7, 2012

Last updated: February 26, 2013

Last verified: October 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	October 2012
Primary Completion Date:	October 2012 (Final data collection date for primary outcome measure)